Interestingly, a few studies revealed that sTREM2 level in the CSF of patients with AD is associated with hallmarks of AD, such as Aβ1–42 [72], total tau, and phosphorylated tau in CSF [30, 31, 32]. This evidence concerns the gene MAPT and Alzheimer disease.